The University Hospital of Montpellier is the oldest medical faculty in Europe, part of the University of Montpellier. It has been rated the 6th best hospital in France.

During the past decade, CHU de Montpellier conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU de Montpellier" are "Candidiasis" (1 trials) and "Relapsed/Refractory Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "CHU de Montpellier" in a lesser frequency.

Most popular intervention types in "CHU de Montpellier" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Brexucabtagene autoleucel" (1 trials), "Cyclophosphamide" (1 trials), "Fludarabine" (1 trials) and "Tests for candidiasis" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Montpellier" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU de Montpellier". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHU de Montpellier, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Montpellier, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".